7.17
price down icon1.78%   -0.13
pre-market  Pre-mercato:  7.11   -0.06   -0.84%
loading

Sage Therapeutics Inc Azioni (SAGE) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
89.87%
7.902
77.97 2.716 2.474 3.294
Operating Expenses
4.61%
125.58
120.05 214.56 172.93 158.76
Benefits Costs and Expenses
5.16%
116.39
110.68 - - 150.12
Costs And Expenses
5.16%
116.39
110.68 214.56 172.93 158.76
Operating Income/Loss
179.69%
-117.67
-42.07 -211.85 -170.46 -155.47
Income/Loss From Continuing Operations Before Tax
231.69%
-108.48
-32.71 2.716 -160.32 -146.83
Income/Loss From Continuing Operations After Tax
231.69%
-108.48
-32.71 -201.63 -160.32 -146.83
Net Income/Loss
231.69%
-108.48
-32.71 -201.63 -160.32 -146.83
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
119.72K%
60.14
0.0502 59.91 59.77 59.67
Diluted Average Shares
119.72K%
60.14
0.0502 59.91 59.77 59.67
Basic Earnings Per Share
233.33%
-1.80
-0.54 -3.37 -2.68 -2.46
Diluted Earnings Per Share
233.33%
-1.80
-0.54 -3.37 -2.68 -2.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.58
price up icon 0.39%
$21.55
price up icon 0.33%
$33.00
price up icon 0.33%
$28.02
price up icon 0.43%
$101.10
price down icon 3.66%
biotechnology ONC
$254.16
price down icon 0.63%
Capitalizzazione:     |  Volume (24 ore):